Who in IPIX is going to establish the clinical trials procedures, end points, etc for human trials for CV19? Leo is not medically trained and I am not sure if Ms. Harness has the knowledge to lead in such matters.
Maybe IPIX hires a medical professional to do such work and pays a fixed amount of shares, maybe the INH,FDA,or other regulatory agencies have trial procedures already established? Hard to believe the top tier of drugs already approved by the FDA didn't have at least one advance to human trials as an anti-viral or anti-inflammatory such that trial procedures were established.
There should be a large number of very good hospitals across the country that could run the tests as all in metropolitan areas have large numbers of CV patients so finding subjects and test site should be no problem.
So where does BP fit in as a sponsor as to the role they are supposed to play?
If above is true that sites and trial procedures have already been established, and we know Brilacidin is now available in quantity to proceed with such trials, human trials should be able to start pretty quickly once the labs give the OK from the lung tissue tests.
My thinking is that there has to be a "standardized" trial for CV drugs because different trial procedures and criteria could lead to different results and allow a lesser drug to get better results than a more powerful drug. I believe Brilacidin is the most powerful drug out there for CV and I don't want to see it get bettered because the playing field wasn't level regarding the human trials.
